Article
Skipping Nonsense to Maintain Function: The Paradigm of BRCA2 Exon 12.
Cancer research - 1 Apr 2020
Meulemans Laëtitia, Mesman Romy L S, Caputo Sandrine M, Krieger Sophie, Guillaud-Bataille Marine, Caux-Moncoutier Virginie, Léone Mélanie, Boutry-Kryza Nadia, Sokolowska Johanna, Révillion Françoise, Delnatte Capucine, Tubeuf Hélène, Soukarieh Omar, Bonnet-Dorion Françoise, Guibert Virginie, Bronner Myriam, Bourdon Violaine, Lizard Sarab, Vilquin Paul, Privat Maud, Drouet Aurélie, Grout Charlotte, Calléja Fabienne M G R, Golmard Lisa, Vrieling Harry, Stoppa-Lyonnet Dominique, Houdayer Claude, Frebourg Thierry, Vreeswijk Maaike P G, Martins Alexandra, Gaildrat Pascaline
Abstract excerpt
Germline nonsense and canonical splice site variants identified in disease-causing genes are generally considered as loss-of-function (LoF) alleles and classified as pathogenic. However, a fraction of such variants could maintain function through their impact on RNA splicing. To test this hypothesis, we used the alternatively spliced BRCA2 exon 12 (E12) as a model system because its in-frame skipping leads to a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
